Indication
Neonatal pneumonia
Neonatal pneumonia is an acute lower respiratory tract infection affecting newborn infants within the first 28 days of life. Read more about Neonatal pneumonia
140 drugs 73 manufacturers
Drugs that treat it
Common Neonatal pneumonia therapies.
ERYTHROMYCIN (erythromycin base)
E.E.S. 400 (erythromycin ethylsuccinate)
ERY-TAB (erythromycin base)
VANCOMYCIN HCL-D5W (vancomycin in 5 % dextrose in water)
VANCOMYCIN HCL
ERYTHROMYCIN (erythromycin base)
VANCOMYCIN HCL
VANCOMYCIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNeonatal pneumonia is an acute lower respiratory tract infection affecting newborn infants within the first 28 days of life.
It can be categorized as congenital, early-onset (typically acquired perinatally via ascending amniotic infection or aspiration during delivery), or late-onset (usually nosocomial or community-acquired).
Pathophysiologically, pathogen invasion triggers alveolar inflammation, impaired gas exchange, and surfactant dysfunction, which frequently presents as respiratory distress—including tachypnea, grunting, retractions, and hypoxemia—or as part of a generalized systemic sepsis syndrome.
Common causative organisms include group B *Streptococcus*, enteric Gram-negative bacilli such as *Escherichia coli*, and other nosocomial or viral pathogens.
- nih.gov
Neonatal pneumonia is an acute lower respiratory tract infection affecting newborn infants within the first 28 days of life It can be categorized as congenital, early-onset (typically acquired perinatally via ascending amniotic infection or aspiration during delivery), or late-onset (usually nosocomial or community-acquired)
- msdmanuals.com
Neonatal pneumonia is an acute lower respiratory tract infection affecting newborn infants within the first 28 days of life Pathophysiologically, pathogen invasion triggers alveolar inflammation, impaired gas exchange, and surfactant dysfunction, which frequently presents as respiratory distress—including tachypnea, grunting, retractions, and hypoxemia—or as part of a generalized systemic sepsis syndrome
- nih.gov
It can be categorized as congenital, early-onset (typically acquired perinatally via ascending amniotic infection or aspiration during delivery), or late-onset (usually nosocomial or community-acquired)
- nih.gov
Pathophysiologically, pathogen invasion triggers alveolar inflammation, impaired gas exchange, and surfactant dysfunction, which frequently presents as respiratory distress—including tachypnea, grunting, retractions, and hypoxemia—or as part of a generalized systemic sepsis syndrome
- intechopen.com
Pathophysiologically, pathogen invasion triggers alveolar inflammation, impaired gas exchange, and surfactant dysfunction, which frequently presents as respiratory distress—including tachypnea, grunting, retractions, and hypoxemia—or as part of a generalized systemic sepsis syndrome
- nih.gov
Common causative organisms include group B *Streptococcus*, enteric Gram-negative bacilli such as *Escherichia coli*, and other nosocomial or viral pathogens
- nih.gov
Common causative organisms include group B *Streptococcus*, enteric Gram-negative bacilli such as *Escherichia coli*, and other nosocomial or viral pathogens
- health.wa.gov.au
Common causative organisms include group B *Streptococcus*, enteric Gram-negative bacilli such as *Escherichia coli*, and other nosocomial or viral pathogens
Personalize your experience
Follow Neonatal pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.